SCHEMBL24631240

SCHEMBL24631240

CNS(=O)(=O)c1ccc(Oc2ccc(C(F)(F)F)cc2)c(-c2ccc3c(c2)OCO3)c1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MAPT P10636 4/20 0.44
▸ PTGS2 P35354 3/20 0.43
▸ ABL1 P00519 1/20 0.42
▸ NPC1 O15118 1/20 0.41
▸ RAB9A P51151 1/20 0.41
▸ ALDH1A1 P00352 3/20 0.41
▸ MEN1 O00255 3/20 0.41
▸ KMT2A Q03164 3/20 0.41
▸ USP2 O75604 1/20 0.41
▸ HSP90AA1 P07900 1/20 0.41
▸ HSP90AB1 P08238 1/20 0.41
▸ PTGS1 P23219 2/20 0.40
▸ PKM P14618 1/20 0.40
▸ TEAD1 P28347 1/20 0.39
▸ SLC6A4 P31645 2/20 0.39
▸ HPGD P15428 1/20 0.39
▸ LMNA P02545 2/20 0.39
▸ HTT P42858 2/20 0.39
▸ SMN1; SMN2 Q16637 2/20 0.39
▸ KDM4E B2RXH2 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30868578 0.83 LMNA (0.48) MAPTABL1ALDH1A1MEN1KMT2A
SCHEMBL24631313 0.83 LMNA (0.48) MAPTABL1ALDH1A1MEN1KMT2A
SCHEMBL30868583 0.83 LMNA (0.42) ABL1ALDH1A1PKMLMNASMN1; SMN2
SCHEMBL24631405 0.83 LMNA (0.42) ABL1ALDH1A1PKMLMNASMN1; SMN2
SCHEMBL30868598 0.79 TEAD1 (0.42) MEN1KMT2ATEAD1LMNAHTT
SCHEMBL24631413 0.79 TEAD1 (0.42) MEN1KMT2ATEAD1LMNAHTT
SCHEMBL30868535 0.78 BRAF (0.45) PTGS2MEN1KMT2APKMTEAD1
SCHEMBL24631171 0.78 BRAF (0.45) PTGS2MEN1KMT2APKMTEAD1
SCHEMBL30868516 0.78 TRIM24 (0.45) MAPTALDH1A1KMT2APKMTEAD1
SCHEMBL27170920 0.78 TRIM24 (0.45) MAPTALDH1A1KMT2APKMTEAD1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240083903-A1 ARYL ETHER COMPOUNDS AS TEAD MODULATORS MERCK SHARP & DOHME LLC (US) 2024-03-14 — — US claimed
US-20240083903-A1 ARYL ETHER COMPOUNDS AS TEAD MODULATORS MERCK SHARP & DOHME LLC (US) 2024-03-14 — — US disclosed
WO-2022177869-A1 ARYL ETHER COMPOUNDS AS TEAD MODULATORS MERCK SHARP & DOHME LLC (US) 2022-08-25 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240083903-A1 ARYL ETHER COMPOUNDS AS TEAD MODULATORS TEAD2, TEAD3, TEAD4 MAPT 1008/4885PTGS2 1879/4885ABL1 78/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback